TABLE 1.
Correlation of circGNB1 expression with clinicopathologic characteristics of triple-negative breast cancer patients.
| Variables | Cases |
circGNB1 |
P-value | |
| Low | High | |||
| Age (y) | ||||
| >50 | 132 | 80(60.6%) | 52(39.4%) | |
| ≤50 | 90 | 58(64.4%) | 32(35.6%) | 0.563 |
| Menopause | ||||
| Yes | 132 | 81(61.4%) | 51(38.6%) | |
| No | 90 | 57(63.3%) | 33(36.7%) | 0.766 |
| Tumor size | ||||
| ≤2.0 cm | 59 | 50(84.7%) | 9(15.3%) | |
| >2.0 cm | 163 | 88(54.0%) | 75(46.0%) | 0.001* |
| Lymph node status | ||||
| Negative | 107 | 73(68.2%) | 34(31.8%) | |
| Positive | 115 | 65(56.5%) | 50(43.5%) | 0.072 |
| TNM stage | ||||
| I-II | 172 | 115(66.9%) | 57(33.1%) | |
| III-IV | 50 | 23(46.0%) | 27(45.0%) | 0.007* |
*P < 0.05, statistically significant.